Wilding G - Search Results

1

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.

Merzianu M, Groman A, Hutson A, Cotta C, Brynes RK, Orazi A, Reddy V, Teruya-Feldstein J, Amre R, Balasubramanian M, Brandao G, Cherian S, Courville E, Czuchlewski D, Fan G, Grier D, Hoehn D, Inamdar KV, Juskevicius R, Kaur P, Lazarchick J, Lewis MR, Miles RR, Myers JB, Nasr MR, Qureishi HN, Olteanu H, Robu VG, Salaru G, Vajpayee N, Vos J, Zhang L, Zhang S, Aye L, Brega E, Coad JE, Grantham J, Ivelja S, McKenna R, Sultan K, Wilding G, Hutchison R, Peterson L, Cheney RT. Merzianu M, et al. Among authors: wilding g. Am J Clin Pathol. 2018 Oct 1;150(5):393-405. doi: 10.1093/ajcp/aqy066. Am J Clin Pathol. 2018. PMID: 30052721 Free PMC article.

2

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.

Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA. Ailawadhi S, et al. Cancer. 2010 Jan 1;116(1):84-92. doi: 10.1002/cncr.24704. Cancer. 2010. PMID: 19862816 Free article. Clinical Trial.

3

Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.

Khoury T, Chandrasekhar R, Wilding G, Tan D, Cheney RT. Khoury T, et al. Among authors: wilding g. Int J Exp Pathol. 2011 Apr;92(2):87-96. doi: 10.1111/j.1365-2613.2010.00745.x. Epub 2010 Nov 2. Int J Exp Pathol. 2011. PMID: 21044186 Free PMC article.

4

Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.

Vaidyanathan G, Groman A, Wilding G, Fakih MG. Vaidyanathan G, et al. Among authors: wilding g. Oncology. 2010;79(1-2):67-71. doi: 10.1159/000319549. Epub 2010 Nov 12. Oncology. 2010. PMID: 21071992

5

Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy.

Khoury T, Zakharia Y, Tan W, Kulkarni S, Liu W, Zhang S, Wilding GE, Edge S. Khoury T, et al. Breast J. 2011 Mar-Apr;17(2):180-6. doi: 10.1111/j.1524-4741.2010.01051.x. Epub 2011 Feb 10. Breast J. 2011. PMID: 21306471

6

Exact two-stage designs for phase II activity trials with rank-based endpoints.

Wilding GE, Shan G, Hutson AD. Wilding GE, et al. Contemp Clin Trials. 2012 Mar;33(2):332-41. doi: 10.1016/j.cct.2011.10.008. Epub 2011 Oct 30. Contemp Clin Trials. 2012. PMID: 22074983

7

An efficient and exact approach for detecting trends with binary endpoints.

Shan G, Ma C, Hutson AD, Wilding GE. Shan G, et al. Among authors: wilding ge. Stat Med. 2012 Jan 30;31(2):155-64. doi: 10.1002/sim.4411. Epub 2011 Dec 9. Stat Med. 2012. PMID: 22162106

8

An examination of the relative impact of type I and type II error rates in phase II drug screening trial queues.

Hutson AD, Wilding GE. Hutson AD, et al. Pharm Stat. 2012 Mar-Apr;11(2):157-62. doi: 10.1002/pst.529. Epub 2012 Jan 10. Pharm Stat. 2012. PMID: 22232067

9

Two-stage k-sample designs for the ordered alternative problem.

Shan G, Hutson AD, Wilding GE. Shan G, et al. Among authors: wilding ge. Pharm Stat. 2012 Jul-Aug;11(4):287-94. doi: 10.1002/pst.1499. Epub 2012 Mar 9. Pharm Stat. 2012. PMID: 22408050

10

A new linear model-based approach for inferences about the mean area under the curve.

Wilding GE, Chandrasekhar R, Hutson AD. Wilding GE, et al. Stat Med. 2012 Dec 10;31(28):3563-78. doi: 10.1002/sim.5387. Stat Med. 2012. PMID: 23175104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters